SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 96 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $96,000 | +37.1% | 11,600 | +12.6% | 0.00% | 0.0% |
Q4 2020 | $70,000 | -84.2% | 10,300 | -74.1% | 0.00% | -90.5% |
Q3 2020 | $443,000 | +41.1% | 39,800 | -20.6% | 0.02% | +23.5% |
Q2 2020 | $314,000 | +554.2% | 50,100 | +92.7% | 0.02% | +466.7% |
Q1 2020 | $48,000 | -4.0% | 26,000 | +168.2% | 0.00% | -25.0% |
Q1 2018 | $50,000 | +35.1% | 9,695 | 0.0% | 0.00% | +33.3% |
Q4 2017 | $37,000 | – | 9,695 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
TRUST CO OF VERMONT | 204 | $19 | 0.00% |
SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |